Τομέας Κλινικοεργαστηριακός

62. Schulpis KH, Papassotiriou I, Parthimos T, Tsakiris T, Tsakiris S. The effect of L-cysteine and glutathione on inhibition of
Na+, K+-ATPase activity by aspartame metabolites in human erythrocyte membranE Eur J Clin Nutr. 2006 May;
60(5):593-7. Impact factor=2,326.
63. Schulpis KH, Papassotiriou I, Tsakiris S. 8-hydroxy-2-desoxyguanosine serum concentrations as a marker of DNA damage
in patients with classical galactosaemia. Acta Paediatr. 2006 Feb; 95(2):164-9. Impact factor=1,411.
64. Tsakiris S, Parthimos T, Parthimos N, Tsakiris T, Schulpis KH. The beneficial effect of L-cysteine supplementation on DNA
oxidation induced by forced traininG Pharmacol Res. 2006 Apr; 53(4):386-90. Impact factor=3,441.
65. Schulpis KH, Giannoulia-Karantana A, Papaconstantinou ED, Parthimos T, Tjamouranis I, Tsakiris S. Erythrocyte membrane
Na+,K+-ATPase and Mg2+-ATPase activities in subjects with methylenetetrahydrofolate reductase (MTHFR) 677 C-->T
genotype and moderate hyperhomocysteinaemia. The role of L-phenylalanine and L-alaninE Clin Chem Lab Med. 2006;
44(4):423-7. Impact factor=1,741.
66. Tsakiris S, Zarros A. Medical physiology and experimentation: reconsidering the undergraduate examination structurE Adv
Physiol Educ. 2006 Jun; 30(2):94-5. Impact factor=0,984.
67. Schulpis KH, Kalimeris K, Bakogiannis C, Tsakiris T, Tsakiris S. The effect of in vitro homocystinuria on the suckling rat
hippocampal acetylcholinesterasE Metab Brain Dis. 2006 Mar; 21(1):21-8. Impact factor=1,831.
68. Tsakiris S, Parthimos T, Tsakiris T, Parthimos N, Schulpis KH. alpha-tocopherol supplementation reduces the elevated 8hydroxy-2-deoxyguanosine
blood levels induced by training in basketball players. Clin Chem Lab Med. 2006; 44(8):1004-
8. Impact factor=1,741.
69. Schulpis KH, Reclos GJ, Parthimos T, Parthimos N, Gavriilidis A, Tsakiris S. L-cysteine supplementation protects the
erythrocyte glucose-6-phosphate dehydrogenase activity from reduction induced by forced traininG Clin Biochem. 2006
Oct; 39(10):1002-6. Impact factor=2,072.
70. Tsakiris S, Reclos GJ, Parthimos T, Tsakiris T, Parthimos N, Schulpis KH. alpha-Tocopherol supplementation restores the
reduction of erythrocyte glucose-6-phosphate dehydrogenase activity induced by forced traininG Pharmacol Res. 2006
Nov; 54(5):373-9. Impact factor=3,441.
71. Tsakiris SI, Uzunoglu NK. Transmission medium and full fiber-optic setup for quantum key distribution applications. Appl
Opt. 2006 Dec 1; 45(34):8764-71. Impact factor=1,701.
72. Drivas S, Rachiotis G, Vlastos FD, Zacharias C, Alexopoulos CG, Symvoulakis M, Vasiliou M, Behrakis PK. Occupational
exposure to lignite and impact on respiratory system among heavy industry personnel. Ind Health. 2007 Jun; 45(3):409-
14. Impact factor=0,792.
73. Parthimos T, Tsopanakis C, Angelogianni P, Schulpis KH, Parthimos N, Tsakiris S. L-cysteine supplementation prevents
exercise-induced alterations in human erythrocyte membrane acetylcholinesterase and Na+,K+-ATPase activities. Clin
Chem Lab Med. 2007; 45(1):67-72. Impact factor=1,741
74. Parthimos T, Tsopanakis C, Angelogianni P, Schulpis KH, Parthimos N, Tsakiris S. The effect of basketball training on the
players' erythrocyte membrane acetylcholinesterase, (Na+,K+)-ATPase and Mg2+-ATPase activities. Int J Sports Med.
2007 Aug; 28(8):650-4. Impact factor=1,524.
75. Simintzi I, Schulpis KH, Angelogianni P, Liapi C, Tsakiris S. The effect of aspartame on acetylcholinesterase activity in hippocampal
homogenates of suckling rats. Pharmacol Res. 2007 Aug; 56(2):155-9. Impact factor=3,441.
76. Simintzi I, Schulpis KH, Angelogianni P, Liapi C, Tsakiris S. L-Cysteine and glutathione restore the reduction of rat hippocampal
Na+, K+-ATPase activity induced by aspartame metabolites. Toxicology. 2007 Jul 31; 237(1-3):177-83. Impact factor=2,919.
77. Simintzi I, Schulpis KH, Angelogianni P, Liapi C, Tsakiris S. The effect of aspartame metabolites on the suckling rat frontal
cortex acetylcholinesterasE An in vitro study. Food Chem Toxicol. 2007 Dec; 45(12):2397-401. Impact factor=2,186.
78. Stathopoulos GP, Koutantos J, Lazaki H, Rigatos SK, Stathopoulos J, Deliconstantinos G Capecitabine (Xeloda) as monotherapy
in advanced breast and colorectal cancer: effectiveness and side-effects. Anticancer Res. 2007 May-Jun;
27(3B):1653-6. Impact factor=1,414.
79. Philippou A, Maridaki M, Halapas A, Koutsilieris M. The role of the insulin-like growth factor 1 (IGF-1) in skeletal muscle
physiology. In Vivo. 2007 Jan-Feb; 21(1):45-54. Impact factor=1,604.
80. Themistocleous GS, Katopodis HA, Khaldi L, Papalois A, Doillon C, Sourla A, Soucacos PN, Koutsilieris M. Implants of type
I collagen gel containing MG-63 osteoblast-like cells can act as stable scaffolds stimulating the bone healing process at
the sites of the surgically-produced segmental diaphyseal defects in male rabbits. In Vivo. 2007 Jan-Feb; 21(1):69-76.
Impact factor=1,604.
81. Koutsilieris M, Dimopoulos T, Milathianakis C, Bogdanos J, Karamanolakis D, Pissimissis N, Halapas A, Lembessis P, Papaioannou
A, Sourla A. Combination of somatostatin analogues and dexamethasone (anti-survival-factor concept) with
luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis. BJU Int.
2007 Jul; 100 Suppl 2:60-2. Impact factor=2,751.
82. Msaouel P, Diamanti E, Tzanela M, Koutsilieris M. Luteinising hormone-releasing hormone antagonists in prostate cancer
therapy. Expert Opin Emerg Drugs. 2007 May; 12(2):285-99. Impact factor=2,725.
2122 ¸êèåóç ÅóùôåñéêÞò Áîéïëüãçóçò (Ðñüôõðï ó÷Þìá)